Skip to main content
TipRanks
Go Ultimate75% OFF

Mycenax Biotech Inc. (4726) Cash flow

Mycenax Biotech Inc. Cash Flow

TW:4726's free cash flow for Q2 2026 was NT$107.12M. For the 2026 fiscal year, TW:4726's free cash flow was decreased by NT$-5.79M and operating cash flow was NT$112.91M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
NT$ -27.24MNT$ -191.68MNT$ -131.18MNT$ -150.19MNT$ -146.23M
NT$ -112.44MNT$ -174.93MNT$ -443.15MNT$ -745.24MNT$ -1.03B
NT$ 94.91MNT$ 116.58MNT$ -229.73MNT$ 1.93BNT$ 1.17B
NT$ 224.54MNT$ 269.56MNT$ 519.27MNT$ 1.32BNT$ 286.93M
NT$ -126.32MNT$ -522.19MNT$ -428.78MNT$ -789.16MNT$ -1.26B

Currency in TWD

Mycenax Biotech Inc. Cash Flow

-2B-1B01B2B3B2019202020212022202320242025OperatingInvestingFinancing